VIR icon

Vir Biotechnology
VIR

Overview Fund Activity

209 hedge funds and large institutions have $3.25B invested in Vir Biotechnology in 2021 Q4 according to their latest regulatory filings, with 59 funds opening new positions, 77 increasing their positions, 56 reducing their positions, and 23 closing their positions.

Holders
209
Holders Change
+35
Holders Change %
+20.11%
% of All Funds
3.23%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.11%
New
59
Increased
77
Reduced
56
Closed
23
Calls
$37M
Puts
$38.2M
Net Calls
-$1.19M
Net Calls Change
-$14M

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$86M
2
Morgan Stanley
2
Morgan Stanley
New York
$51.5M
3
Millennium Management
3
Millennium Management
New York
$40.5M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$25M
5
AllianceBernstein
5
AllianceBernstein
Tennessee
$110M

Top Sellers

1
Capital International Investors
1
Capital International Investors
California
$231M
2
APF
2
Alaska Permanent Fund
Alaska
$79M
3
SIAU
3
SB Investment Advisers (UK)
United Kingdom
$930M
4
OIM
4
Oracle Investment Management
Connecticut
$36.1M
5
Bank Julius Baer & Co
5
Bank Julius Baer & Co
Switzerland
$5.68M
Name Holding Trade Value Shares
Change 		Shares
Change %
OSAM
226
O'Shaughnessy Asset Management
Connecticut
– -$44K -1,012 Closed
RE
227
RBC Europe
United Kingdom
– -$35.7K -820 Closed
ADL
228
Asset Dedication LLC
California
– -$4K -100 Closed
6 7 8 9
10